about
Weak, strong, and coherent regimes of Fröhlich condensation and their applications to terahertz medicine and quantum consciousnessPenrose-Hameroff orchestrated objective-reduction proposal for human consciousness is not biologically feasibleThe Cys3-Cys4 loop of the hydrophobin EAS is not required for rodlet formation and surface activityA dynamic pharmacophore drives the interaction between Psalmotoxin-1 and the putative drug target acid-sensing ion channel 1aMissing Fragments: Detecting Cooperative Binding in Fragment-Based Drug DesignGROMACS: fast, flexible, and freeMolecular dynamics simulations from putative transition states of alpha-spectrin SH3 domain.Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop.Combination of Ambiguous and Unambiguous Data in the Restraint-driven Docking of Flexible Peptides with HADDOCK: The Binding of the Spider Toxin PcTx1 to the Acid Sensing Ion Channel (ASIC) 1a.Validating lipid force fields against experimental data: Progress, challenges and perspectives.Deriving Structural Information from Experimentally Measured Data on Biomolecules.The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study.Mimicking the action of folding chaperones by Hamiltonian replica-exchange molecular dynamics simulations: application in the refinement of de novo models.Simulation of pore formation in lipid bilayers by mechanical stress and electric fields.Mechanism of activation of protein kinase JAK2 by the growth hormone receptor.Vancomycin: ligand recognition, dimerization and super-complex formation.The effect of membrane curvature on the conformation of antimicrobial peptides: implications for binding and the mechanism of action.Structural characterization of two metastable ATP-bound states of P-glycoprotein.The characterization of modified starch branching enzymes: toward the control of starch chain-length distributionsThe effect of environment on the recognition and binding of vancomycin to native and resistant forms of lipid II.Molecular dynamics and functional studies define a hot spot of crystal contacts essential for PcTx1 inhibition of acid-sensing ion channel 1a.The Role of histidine residues in low-pH-mediated viral membrane fusion.Charge group partitioning in biomolecular simulationDisturb or stabilize? A molecular dynamics study of the effects of resorcinolic lipids on phospholipid bilayersThe CC domain structure from the wheat stem rust resistance protein Sr33 challenges paradigms for dimerization in plant NLR proteins.Basic ingredients of free energy calculations: a review.The revised Penrose-Hameroff orchestrated objective-reduction proposal for human consciousness is not scientifically justified: comment on "Consciousness in the universe: a review of the 'Orch OR' theory" by Hameroff and Penrose.Validation of Molecular Simulation: An Overview of Issues.Revisiting the scissor-like mechanism of activation for the erythropoietin receptor.Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.Using Theory to Reconcile Experiment: The Structural and Thermodynamic Basis of Ligand Recognition by Phenylethanolamine N-Methyltransferase (PNMT).Lipid Bilayers: The Effect of Force Field on Ordering and Dynamics.The Effect of Environment on the Structure of a Membrane Protein: P-Glycoprotein under Physiological Conditions.Molecular view of hexagonal phase formation in phospholipid membranes.Histidine protonation and the activation of viral fusion proteins.Ion transport across transmembrane poresCalcium binding to the purple membrane: A molecular dynamics study.Some Like It Hot: The Effect of Sterols and Hopanoids on Lipid Ordering at High Temperature.Construction and molecular dynamics simulation of calmodulin in the extended and in a bent conformation.Calculation of the free energy of solvation for neutral analogs of amino acid side chains.
P50
Q24656097-38B1005C-FA25-490A-ADD0-BB107C38355CQ27355514-81B71309-8068-4588-96EA-7B371A032FABQ27651394-FF783874-E768-474A-96F8-3925DAAA4314Q27671613-02FEE257-7917-4C3E-AE33-0B3691EED986Q27684142-9ABA35EA-A0BC-45F0-8A70-814ACD384969Q27860998-D5E8E69D-25A2-42C9-B3EE-DC411F8DF4F3Q30157923-19A554B8-18A7-4400-826A-9E5B47CBBD4EQ30277026-7760B6DD-EDAC-401E-8A8D-CEF0863A8BF4Q31030631-D2576EF7-3903-4684-BCBA-4D24649CBDC6Q31043327-8F869097-9ECC-4205-B717-C7FEFD257527Q31143273-EBD09BF9-DD75-4706-BD4E-CDC7E80CDFC8Q34005469-97C62464-93CF-438C-AB1F-0453EA85F3F2Q34192586-4B0AE5B5-D620-4182-BEC0-E08A472103DFQ34202777-4576DEF8-5A33-429D-B6E4-833722C51329Q34420222-F2C6520D-2691-40EA-AD75-952CA678741EQ34539275-DB984989-69B4-4F9A-B86B-843A488C1655Q34757081-B5F3A73C-D159-4318-8F61-5CE9662DA2E3Q35121898-282BC171-27CC-4822-9DAB-9A3C9B442537Q35393930-D9808EB2-E599-4091-A1E4-A66BADE4764EQ35815846-3089D04E-F728-4167-BE71-4F1BA3D95A98Q36211191-ADD47522-B683-45D9-B144-8E6628DA1BA5Q36617056-5F54E87C-6800-45EA-9367-B443F29D574FQ36664425-326D017E-AFE7-4D23-8EBA-59E0C2E810AAQ37282298-D84EBFF0-A09B-4E5E-85F6-BE8630E1E70AQ37417964-DDD7844D-D7DD-4BE1-8CE2-A0E45E1F46E4Q37662435-92FEA359-9881-46FC-B0B8-43918DCB71DBQ38165510-0590379D-C149-44D1-AAB4-7F2C588EA446Q38691259-6B993061-F6D9-4FC0-823F-48517473F8FEQ38918037-5A5C61AD-FEBD-4465-9CBA-ABC837A30E87Q39677574-D3925195-E7DB-4974-84A1-B3B7701375EFQ40271775-E180961B-4C23-4C9B-AA20-8E2B07637A1FQ40276945-97F335C3-05F1-4EC6-884A-BFDA6685BE95Q40290755-A61CF43A-5D0D-4BD0-AB88-181166BAA05FQ40308003-2527A442-4C0B-4A82-AE30-D40C57D77D8EQ40429159-36D74E1D-9587-41A5-8909-4DAF128B264BQ42773684-BAB6F289-C045-463E-AF26-059E27B78EAFQ43025211-65A3E8ED-7AAC-4B00-A878-C8A73DD5579CQ43025400-39530EE1-908C-4524-A882-A6C0449F3718Q43411990-C92DDC9D-8A56-4A2B-8762-4BEFD7B2825FQ43956197-8FFDF73F-F75E-473A-BA62-673690E150FC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alan E Mark
@ast
Alan E Mark
@en
Alan E Mark
@es
Alan E Mark
@nl
type
label
Alan E Mark
@ast
Alan E Mark
@en
Alan E Mark
@es
Alan E Mark
@nl
altLabel
Alan Mark
@en
prefLabel
Alan E Mark
@ast
Alan E Mark
@en
Alan E Mark
@es
Alan E Mark
@nl
P1053
A-8799-2011
P106
P21
P2456
P31
P3829
P496
0000-0001-5880-4798